Cargando...
The Use of Gene Therapy for Ablation of Atrial Fibrillation
Atrial fibrillation is the most common clinically significant cardiac arrhythmia, increasing the risk of stroke, heart failure and morbidity and mortality. Current therapies, including rate control and rhythm control by antiarrhythmic drugs or ablation therapy, are moderately effective but far from...
Gardado en:
| Publicado en: | Arrhythm Electrophysiol Rev |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Radcliffe Cardiology
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4711550/ https://ncbi.nlm.nih.gov/pubmed/26835081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/aer.2014.3.3.139 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|